Correction: Molecular surveillance of pfhrp2 and pfhrp3 deletions in Plasmodium falciparum isolates from Mozambique (Malaria Journal (2017) 16 (416) DOI: 10.1186/s12936-017-2061-z);Molecular surveillance of pfhrp2 and pfhrp3 deletions in Plasmodium falciparum isolates from Mozambique

Malaria Journal

Volumn 16, Issue 1, 2017, Pages

  Gupta, Himanshu ^a   Matambisso, Gloria ^b   Galatas, Beatriz ^a,b   Cisteró, Pau ^a   Nhamussua, Lidia ^b   Simone, Wilson ^b   Cunningham, Jane ^c   Rabinovitch, N Regina ^a,d   Alonso, Pedro ^a,b   Saute, Franciso ^a,b   Aide, Pedro ^b,e   Mayor, Alfredo ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Manhiça Health Research Center   (Mozambique)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

Author keywords

Deletion; Malaria; Mozambique; Pfhrp2; RDT

Indexed keywords

RNA 18S; HRP-2 ANTIGEN, PLASMODIUM FALCIPARUM; HRP3 PROTEIN, PLASMODIUM FALCIPARUM; PARASITE ANTIGEN; PROTOZOAL PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENE; GENE AMPLIFICATION; GENE DELETION; HUMAN; KELCH GENE; MAJOR CLINICAL STUDY; MALARIA; MALE; MICROSCOPY; MOLECULAR EPIDEMIOLOGY; MOZAMBIQUE; NONHUMAN; PFHRP2 GENE; PFHRP3 GENE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREVALENCE; QUANTITATIVE ANALYSIS; AMINO ACID SEQUENCE; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; GENETICS; MALARIA FALCIPARUM; STATISTICS AND NUMERICAL DATA;

AMINO ACID SEQUENCE; ANTIGENS, PROTOZOAN; DIAGNOSTIC ERRORS; DIAGNOSTIC TESTS, ROUTINE; MALARIA, FALCIPARUM; MOZAMBIQUE; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; SEQUENCE DELETION;

EID: 85031688168     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-017-2111-6     Document Type: Erratum

References (18)

1. Bloland P. Drug resistance in malaria. Geneva, World Health Organization, 2001. http://www.who.int/csr/resources/publications/drugresist/malaria.pdf.
2. WHO. False-negative RDT results and implications of new reports of Plasmodium falciparum histidine-rich protein 2/3 gene deletions. Geneva: World Health Organization; 2016. http://www.finddx.org/wp-content/uploads/2016/06/WHO-information-note-false-neg-rdt-results-May2016.pdf.
3. WHO. Plasmodium falciparum hrp2/3gene deletions. Malaria Policy Advisory Committee Meeting. Geneva: World Health Organization; 2016. http://www.who.int/malaria/mpac/mpac-sept2016-hrp2-consultation-short-report-session7.pdf.
4. Wongsrichanalai C, Barcus MJ, Muth S, Sutamihardja A, Wernsdorfer WH. A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT). Am J Trop Med Hyg. 2007;77:119-27.
5. Baker J, McCarthy J, Gatton M, Kyle DE, Belizario V, Luchavez J, et al. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J Infect Dis. 2005;192:870-7.
6. Lee N, Baker J, Andrews KT, Gatton ML, Bell D, Cheng Q, et al. Effect of sequence variation in Plasmodium falciparum histidine-rich protein 2 on binding of specific monoclonal antibodies: implications for rapid diagnostic tests for malaria. J Clin Microbiol. 2006;44:2773-8.
7. Berhane A, Russom M, Bahta I, Hagos F, Ghirmai M, Uqubay S. Rapid diagnostic tests failing to detect Plasmodium falciparum infections in Eritrea: an investigation of reported false negative RDT results. Malar J. 2017;16:105.
8. President's malaria initiative-FY 2014 Mozambique malaria operational plan. https://www.pmi.gov/docs/default-source/default-document-library/malaria-operational-plans/fy14/mozambique-mop-fy14.pdf.
9. Galatas B, Guinovart C, Bassat Q, Aponte JJ, Nhamússua L, Macete E, et al. A prospective cohort study to assess the micro-epidemiology of Plasmodium falciparum clinical malaria in Ilha Josina Machel (Manhiça, Mozambique). Malar J. 2016;15:444.
10. Ménard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016;374:2453-64.
11. Gamboa D, Ho M, Bendezu J, Torres K, Chiodini P, Barnwell J, et al. A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS ONE. 2010;5:e8091.
12. Mayor A, Serra-Casas E, Bardají A, Sanz S, Puyol L, Cisteró P, et al. Sub-microscopic infections and long-term recrudescence of Plasmodium falciparum in Mozambican pregnant women. Malar J. 2009;8:9.
13. Taylor SM, Mayor A, Mombo-Ngoma G, Kenguele HM, Ouédraogo S, Ndam NT, et al. A quality control program within a clinical trial Consortium for PCR protocols to detect Plasmodium species. J Clin Microbiol. 2014;52:2144-9.
14. Bharti PK, Chandel HS, Ahmad A, Krishna S, Udhayakumar V, Singh N. Prevalence of pfhrp2 and/or pfhrp3 gene deletion in Plasmodium falciparum population in eight highly endemic states in India. PLoS ONE. 2016;11:e0157949.
15. Wurtz N, Fall B, Bui K, Pascual A, Fall M, Camara C, et al. Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests. Malar J. 2013;12:34.
16. Koita OA, Doumbo OK, Ouattara A, Tall LK, Konaré A, Diakité M, et al. False-negative rapid diagnostic tests for malaria and deletion of the histidine-rich repeat region of the hrp2 gene. Am J Trop Med Hyg. 2012;86:194-8.
17. Amoah LE, Abankwa J, Oppong A. Plasmodium falciparum histidine rich protein-2 diversity and the implications for PfHRP 2: based malaria rapid diagnostic tests in Ghana. Malar J. 2016;15:101.
18. Hofmann N, Mwingira F, Shekalaghe S, Robinson LJ, Mueller I, Felger I. Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med. 2015;12:e1001788.